UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169

Sortiert nach

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Leukemia, 2010-02, Vol.24 (2), p.265-284

2010

Volltextzugriff (PDF)

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia

Leukemia, 2017-05, Vol.31 (5), p.1087-1095

2017

Volltextzugriff (PDF)

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR

Annals of oncology, 2020-03, Vol.31 (3), p.422-429

2020

Volltextzugriff (PDF)

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

Haematologica (Roma), 2012-01, Vol.97 (1), p.21-29

2012

Volltextzugriff (PDF)

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004

Leukemia, 2017-12, Vol.31 (12), p.2807-2814

2017

Volltextzugriff (PDF)

High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children

Bone marrow transplantation (Basingstoke), 2005-07, Vol.36 (2), p.135-138

2005

Volltextzugriff (PDF)

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report

Leukemia, 2012-04, Vol.26 (4), p.654-661

2012

Volltextzugriff (PDF)

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

Klinische Padiatrie, 2015-05, Vol.227 (3), p.157

2015

Volltextzugriff (PDF)

Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (4), p.329-333

2007

Volltextzugriff (PDF)

Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival

Leukemia, 2015-11, Vol.29 (11), p.2260-2263

2015

Volltextzugriff (PDF)

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.651-656

2013

Volltextzugriff (PDF)

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Klinische Padiatrie, 2013-05, Vol.225 Suppl 1, p.S62

2013

Volltextzugriff (PDF)

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry

Journal of clinical oncology, 1998-03, Vol.16 (3), p.953-965

1998

Volltextzugriff (PDF)

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

Leukemia, 2005-06, Vol.19 (6), p.971-977

2005

Volltextzugriff (PDF)

Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004

Klinische Padiatrie, 2015-05, Vol.227 (3), p.116

2015

Volltextzugriff (PDF)

Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age

Cancer letters, 2003-07, Vol.197 (1), p.11-17

2003

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I

Klinische Padiatrie, 2009-11, Vol.221 (6), p.351

2009

Volltextzugriff (PDF)

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.815-821

2004

Volltextzugriff (PDF)

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

Leukemia, 2009-07, Vol.23 (7), p.1355-1358

2009

Volltextzugriff (PDF)

High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma

Bone marrow transplantation (Basingstoke), 2003-02, Vol.31 (4), p.281-284

2003

Volltextzugriff (PDF)

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.893-898

2002

Volltextzugriff (PDF)

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

The lancet oncology, 2005-09, Vol.6 (9), p.649-658

2005

Volltextzugriff (PDF)

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

Annals of oncology, 2001-11, Vol.12 (11), p.1619-1630

2001

Volltextzugriff (PDF)

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions

European journal of cancer (1990), 1997-10, Vol.33 (12), p.2130-2135

1997

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

Journal of clinical oncology, 1997-02, Vol.15 (2), p.566-573

1997

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(99)
Science & Technology
(91)
Life Sciences & Biomedicine
(77)
Child
(64)
Child, Preschool
(61)
Female
(60)
Male
(58)
Biological And Medical Sciences
(52)
Medical Sciences
(51)
Adolescent
(44)
Infant
(43)
Hematology
(38)
Oncology
(38)
Pediatrics
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Stem Cell Transplantation
(24)
Combined Modality Therapy
(23)
Treatment Outcome
(21)
Survival Rate
(19)
Transplantation
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004

High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia

Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood

Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004

Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age

Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

Suchergebnisse filtern